Analysts expect Acrivon Therapeutics, Inc. to report revenue of 0.00 for Q3 26, against a range of 0.00 to 0.00. The most recent reported quarter, Q2 26, came in at 0.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 160,254.64 | 274,880.24 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.88 M | 4.64 M | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 150,336.84 | 251,706.72 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.36 M | 4.01 M | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 155,295.74 | 263,293.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.62 M | 4.32 M |
Analysts expect Acrivon Therapeutics, Inc. to report earnings per share of -0.47 for Q3 26, against a range of -0.50 to -0.44. The most recent reported quarter, Q2 26, came in at -0.43, a 8.5% beat against the -0.47 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -0.59 | -0.60 | -0.51 | -0.55 | -0.47 | -0.49 | -0.49 | -0.43 | - | - | - | - | - | - | - | - | ||||||||||
| High Estimate | -0.51 | -0.64 | -0.64 | -0.53 | -0.55 | -0.43 | -0.46 | -0.44 | -0.44 | -0.42 | -0.44 | -0.42 | -0.37 | -0.41 | -0.39 | -0.35 | ||||||||||
| Low Estimate | -0.61 | -0.76 | -0.68 | -0.57 | -0.65 | -0.49 | -0.50 | -0.50 | -0.50 | -0.46 | -0.50 | -0.48 | -0.39 | -0.47 | -0.45 | -0.39 | ||||||||||
| Consensus Estimate | -0.56 | -0.70 | -0.66 | -0.55 | -0.60 | -0.46 | -0.48 | -0.47 | -0.47 | -0.44 | -0.47 | -0.45 | -0.38 | -0.44 | -0.42 | -0.37 |